Recombinant human erythropoietin (Shenzhen Xinpeng Bio-tech)
重组人促红素注射液（未名新鹏）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human erythropoietin (Shenzhen Xinpeng Bio-tech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2005/03/29
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Sinobioway Xinpeng Biomedicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShenzhen Sinobioway Xinpeng Biomedicine Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A